Latest News for: Gedeon Richter

Edit

Prader-Willi Syndrome Market Size in the 7MM was USD 600 Million in 2023, estimated DelveInsight

GetNews 20 Nov 2024
Gedeon Richter Plc ARD-101 ... Pfizer, Soleno Therapeutics, Neuren Pharmaceuticals, Harmony Biosciences, Gedeon Richter Plc, Montefiore Medical Center, Aardvark Therapeutics, ACADIA Pharmaceuticals, and others Key Prader-Willi Syndrome Therapies.
Edit

Research with Gedeon Richter Unveils Key Brain Effects of Antipsychotic Drugs

Hungary Today 18 Nov 2024
By combining the expertise of KOKI researchers with the resources of Gedeon Richter, it demonstrates how Hungarian intellectual capital can lead to globally impactful outcomes.
Edit

Richter Sees Robust Sales, Fueled by Pharma Revenue

Hungary Today 13 Nov 2024
Gedeon Richter’s headquarters in Budapest ... Gedeon Richter, headquartered in Budapest, Hungary, is a major pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Latin America, and Australia.
Edit

Bipolar Depression Market Size in the 7MM is expected to grow by 2034, estimated DelveInsight

GetNews 12 Nov 2024
The leading Bipolar Depression Companies such as Allergan (AbbVie)/Gedeon Richter, Alkermes, Glaxo SmithKline (GSK), ELI Lilly and Company, Janssen Pharmaceuticals, Astellas Pharma Inc., Bristol Myers Squibb, Gedeon Richter Plc., H.
Edit

Extraordonary announcement (Gedeon Richter plc)

Public Technologies 12 Nov 2024
Gedeon Richter Plc ... Gedeon Richter Italia S.r.l ... TOO "GEDEON RICHTER KZ" ... GEDEON RICHTER USA INC ... GEDEON RICHTER PHARMA GmbH ... GEDEON RICHTER IBÉRICA, S.A ... GEDEON RICHTER - RUS JSC ... GEDEON RICHTER PHARMACEUTICAL ... GEDEON RICHTER POLSKA SP.Z.O.O.
Edit

Gedeon Richter Q3 investor presentation (Gedeon Richter plc)

Public Technologies 12 Nov 2024
Gedeon Richter Investor presentation ... Gedeon Richter A European specialty mid-pharma company ... Richter focus ... Gedeon Richter ... Gedeon Richter plc published this content on November 12, 2024, and is solely responsible for the information contained herein.
Edit

Richter publishes Q3 results (Gedeon Richter plc)

Public Technologies 12 Nov 2024
Budapest, 12 November 2024 -Gedeon Richter Plc ... About Gedeon Richter Plc. Gedeon Richter Plc ... Gedeon Richter plc published this content on November 12, 2024, and is solely responsible for the information contained herein.
Edit

2024 I-III. negyedévi befektetői prezentáció (Gedeon Richter plc)

Public Technologies 12 Nov 2024
Gedeon Richter Investor presentation ... Gedeon Richter A European specialty mid-pharma company ... Richter focus ... Gedeon Richter ... Gedeon Richter plc published this content on November 12, 2024, and is solely responsible for the information contained herein.
Edit

Earnings presentation Q3 2024 (Gedeon Richter plc)

Public Technologies 12 Nov 2024
Gedeon Richter ... Gedeon Richter plc published this content on November 12, 2024, and is solely responsible for the information contained herein.
Edit

Interim management statement (Gedeon Richter plc)

Public Technologies 12 Nov 2024
Gedeon Richter ... Gedeon Richter plc published this content on November 12, 2024, and is solely responsible for the information contained herein.
Edit

Voting rights, registered capital (Gedeon Richter plc)

Public Technologies 31 Oct 2024
Chemical Works of Gedeon Richter Plc ... Richter Plc ... Gedeon Richter Plc ... Gedeon Richter plc published this content on October 31, 2024, and is solely responsible for the information contained herein.
Edit

AbbVie (ABBV) Reports Third-Quarter 2024 Financial Results

MarijuanaStocks 30 Oct 2024
AbbVie Reports Third-Quarter 2024 Financial Results ... Third-Quarter Results ... AbbVie and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions ... —.
Edit

Major Depressive Disorder Market Expected to Experience Major Growth by 2034, According to DelveInsight | ...

GetNews 29 Oct 2024
To Know in detail about the Major Depressive Disorder market outlook, drug uptake, treatment scenario and epidemiology trends, Click here;. Key Highlights from Major Depressive Disorder market Report. ... AbbVie and Gedeon Richter Plc ... SAGE-217 ... REL-1017 ... 1.
Edit

AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets ...

Malvern Daily Record 25 Oct 2024
Companies will discover and develop novel targets for the potential treatment of neuropsychiatric conditions New discovery program builds upon nearly two decades of partnership between AbbVie and Gedeon Richter ... .
Edit

Richter Announces Collaboration with U.S. Pharmaceutical Company

Hungary Today 25 Oct 2024
Gábor Orbán, CEO of Gedeon Richter, said that this new agreement builds on their long-standing successful partnership and will enable Richter to further support AbbVie’s global efforts in ...

Most Viewed

×